Gábor Gieszinger

Dr. Gábor Gieszinger

Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Csongrád, Hungary
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Gábor GieszingerGábor Gieszinger
Gábor Gieszinger
BKBalázs Kui
Balázs Kui
Peter HegyiPeter Hegyi
Peter Hegyi
Peter HegyiPeter Hegyi
Peter Hegyi
Aron VinczeAron Vincze
Aron Vincze
László CzakóLászló Czakó
László Czakó
Background: Hypercalcemia is a rare etiology of acute pancreatitis; only a few cases have been reported in the literature, and the severity of hypercalcemia-induced AP is unknown. We aimed to assess the occurrence and severity of hypercalcemia-induced AP and compare it with the clinical characteristics of AP caused by other etiological factors. Methods: We collected data from patients from the Hungarian Acute Pancreatitis Registry who had AP, a serum calcium level above 2.6 mmol/L, and no other AP etiology. AP patients with etiologies other than hypercalcemia served as control. Results: A total of 1.20% of our AP patients (16/1328) had a clear hypercalcemic etiology, 5.05% (67/1328) had a mixed etiology, and 1245 patients were in the control group. Severe AP, organ failure, and renal failure were significantly more common in patients with hypercalcemia-induced AP than in the control or the mixed etiology groups. Heart failure was significantly more frequent in the clear hypercalcemia-induced group than in patients with normal serum calcium AP. Respiratory failure was significantly more common in the clear hypercalcemia-induced AP group than in the mixed etiology-induced group. There was no significant difference in other analyzed parameters. The outcome of AP was not associated with the severity of hypercalcemia within the hypercalcemic group. Conclusions: Compared with AP of different etiologies, hypercalcemia-induced AP is more likely to develop into severe AP and organ failure (heart and kidneys).

1 July 2026 in Magyar Belorvosi Archívum
Verified
Journal Article
Open access
PDF file
Gábor GieszingerGábor Gieszinger
Gábor Gieszinger
László CzakóLászló Czakó
László Czakó
A pancreas adenocarcinoma élettartam incidenciája 1,3%, viszont az incidenciája és mortalitása is egyaránt növekvő tendenciát mutat. A daganat igen rossz prognózisú, az 5 éves túlélés 10–13% körül van. Az igen gyakori előfordulásra és rossz kimenetelre való tekintettel merül fel a kérdés, hogy szűréssel javítható-e ezen betegség prognózisa, és ha igen, kiket és hogyan is szűrjünk?